Dynamics of oxidative/nitrosative stress in mice with methionine-choline- deficient diet-induced nonalcoholic fatty liver disease

Human and Experimental Toxicology

Volumn 33, Issue 7, 2014, Pages 701-709

  Jorgacvic B ^a   Mladenovic D ^a   Ninkovic M ^b   Prokic V ^b   Stankovic M N ^a   Aleksic V ^a   Cerovic I ^c   Vukićević, R Ješić ^c   Vucvic D ^a   Stankovic M ^a   Radosavljevic T ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

methionine choline deficient diet; mice; Nonalcoholic fatty liver disease; oxidative nitrosative stress

Indexed keywords

ACUTE PHASE PROTEIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CATALASE; CHOLINE; COPPER ZINC SUPEROXIDE DISMUTASE; FERRITIN; GLUTATHIONE; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; METHIONINE; NITRATE; NITRITE; SUPEROXIDE DISMUTASE; ANTIOXIDANT; NITRIC ACID DERIVATIVE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL DEGENERATION; CELL SWELLING; CONTROLLED STUDY; DIET; ENZYME ACTIVITY; FATTY LIVER; FERRITIN BLOOD LEVEL; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; LIPID PEROXIDATION; LIPID STORAGE; LIVER CELL; MALE; METHIONINE CHOLINE DEFICIENT DIET; MOUSE; NITROSATIVE STRESS; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL DEFICIENCY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ANIMAL; BLOOD; C57BL MOUSE; COMPLICATION; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; TIME; VITAMIN DEFICIENCY;

ANIMALS; ANTIOXIDANTS; C-REACTIVE PROTEIN; CATALASE; CHOLINE DEFICIENCY; DISEASE MODELS, ANIMAL; FERRITINS; GLUTATHIONE; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; METHIONINE; MICE, INBRED C57BL; NITRATES; NITRITES; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 84903523617     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327113506723     Document Type: Article

References (32)

1. Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol. 2010 ; 5: 145-171
2. Petta S, Muratore C, Craxì A. Non-alcoholic fatty liver disease pathogenesis: the present and the future. Dig Liver Dis. 2009 ; 41: 615-625
3. Grattagliano I, de Bari O, Bernardo TC, Oliveira PJ, Wang DQ, Portincasa P. Role of mitochondria in nonalcoholic fatty liver disease from origin to propagation. Clin Biochem. 2012 ; 45: 610-618
4. Koek GH, Liedorp PR, Bast A. The role of oxidative stress in non-alcoholic steatohepatitis. Clin Chim Acta. 2011 ; 412: 1297-1305
5. Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med. 2012 ; 52: 59-69
6. Hardwick RN, Fisher CD, Canet MJ, Lake AD, Cherrington NJ. Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease. Drug Metab Dispos. 2010 ; 38: 2293-2301
7. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007 ; 87: 315-424
8. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951 ; 193: 265-275
9. Saso L, Silvestrini B, Lahita R, Cheng CY. Changes of immunoreactivity in alpha 1-antitrypsin in patients with autoimmune diseases. Inflammation. 1993 ; 17: 383-400
10. Panrucker DE, Lorscheider FL. Radioimmunoassay of rat acute-phase alpha 2-macroglobulin. Biochim Biophys Acta. 1982 ; 705: 184-191
11. Girotti M, Khan N, McLellan BA. Early measurement of systemic lipid peroxidation products in the plasma of major blunt trauma patients. J Trauma. 1991 ; 31: 32-35
12. Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 1988 ; 157: 87-94
13. Sun M, Zigman S. An improved spectrophotometric assay for superoxide dismutase based on epinephrine autooxidation. Anal Biochem. 1978 ; 90: 81-90
14. Beers RF, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952 ; 195: 133-140
15. Anderson ME The DTNB-GSSG reductase recycling assay for total glutathione. Greenwald RA, ed. Boca Raton, FL: CRC Press ; 1986: 317-323.
16. Sundaresan S, Vijayagopal P, Mills N, Imrhan V, Prasad C. A mouse model for nonalcoholic steatohepatitis. J Nutr Biochem. 2011 ; 22: 979-984
17. Varela-Rey M, Embade N, Ariz U, Lu SC, Mato JM, Martínez-Chantar ML. Non-alcoholic steatohepatitis and animal models: understanding the human disease. Int J Biochem Cell Biol. 2009 ; 41: 969-976
18. Marcolin E, Forgiarini LF, Tieppo J, Dias AS, Freitas LA, Marroni NP. Methionine and choline deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis. Arq Gastroenterol. 2011 ; 48: 72-79
19. Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, et al. Alpha lipoic acid attenuates methionine choline deficient diet induced steatohepatitis in C57BL/6 mice. Life Sci. 2012 ; 90: 200-205
20. Singh R, Wang Y, Schattenberg JM, Xiang Y, Czaja MJ. Chronic oxidative stress sensitizes hepatocytes to death from 4-hydroxynonenal by JNK/c-Jun overactivation. Am J Physiol Gastrointest Liver Physiol. 2009 ; 297: G907 - G917
21. Nishida T, Tsuneyama K, Fujimoto M, Nomoto K, Hayashi S, Miwa S, et al. Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome. Lab Invest. 2013 ; 93: 230-241
22. Svegliati-Baroni G, Saccomano S, van Goor H, Jansen P, Benedetti A, Moshage H. Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. Liver. 2001 ; 21: 1-12
23. Kathirvel E, Chen P, Morgan K, French SW, Morgan TR. Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver. J Gastroenterol Hepatol. 2010 ; 25: 1136-1143
24. Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol. 2009 ; 51: 212-223
25. Garcia-Monzon C, Majano PL, Zubia I, Sanz P, Apolinario A, Moreno-Otero R. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis associates with histological severity of liver disease. J Hepatol. 2000 ; 32: 331-338
26. Videla LA, Rodrigo R, Orellana M, Fernandez V, Tapia G, Quiñones L,. Oxidative stress related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci. 2004 ; 106: 261-268
27. Angulo P. Current best treatment for non-alcoholic fatty liver disease. Opin Pharmacother. 2003 ; 4: 611-623
28. Aubert J, Bergiche K, Knockaert L, Robin MA, Fromenty B. Increased expression of cytochrome P4502E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role. Clin Res Hepatol Gastroenterol. 2011 ; 35: 630-637
29. Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013 ; 1830: 3143-3153
30. Khoshbaten M, Aliasgarzadeh A, Masnadi K, Tarzamani MK, Farhang S, Babaei H,. N-acetylcysteine improves liver function in patients with non-alcoholic fatty liver disease. Hepat Mon. 2010 ; 10: 12-16
31. Uzun MA, Koksal N, Kadioglu H, Gunerhan Y, Aktas S, Dursun N, et al. Effects of N-acetylcysteine on regeneration following partial hepatectomy in rats with nonalcoholic fatty liver disease. Surg Today. 2009 ; 39: 592-597
32. Haque JA, McMahan RS, Campbell JS, Shimizu-Albergine M, Wilson AM, Botta D, et al. Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice. Lab Invest. 2010 ; 90: 1704-1717